Daniel Macías-García

Daniel Macías-García

Auto-generated profile, based on publicly available information

Daniel Macías-García

Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, 41013, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in Movement Disorders
Verified
Journal Article
Open access
LMLaura Muñoz‐Delgado
Laura Muñoz‐Delgado
MLMiguel Ángel Labrador‐Espinosa
Miguel Ángel Labrador‐Espinosa
DMDaniel Macías‐García
Daniel Macías‐García
SJSilvia Jesús
Silvia Jesús
BZBelén Benítez Zamora
Belén Benítez Zamora
PMPablo Mir
Pablo Mir
Background: Peripheral inflammatory immune responses are suggested to play a major role in dopaminergic degeneration in Parkinson's disease (PD). The neutrophil‐to‐lymphocyte ratio (NLR) is a well‐established biomarker of systemic inflammation in PD. Degeneration of the nigrostriatal dopaminergic system can be assessed in vivo using [123I]FP‐CIT single photon emission computed tomography imaging of striatal dopamine transporter (DAT) density.Objectives: To assess the relationship between the peripheral immune profile (NLR, lymphocytes, and neutrophils) and striatal DAT density in patients with PD.Methods: We assessed clinical features, the peripheral immune profile, and striatal [123I]FP‐CIT DAT binding levels of 211 patients with PD (primary‐cohort). Covariate‐controlled associations between the immune response and striatal DAT levels were assessed using linear regression analyses. For replication purposes, we also studied a separate cohort of 344 de novo patients with PD enrolled in the Parkinson's Progression Markers Initiative (PPMI‐cohort).Results: A higher NLR was significantly associated with lower DAT levels in the caudate (primary‐cohort: β = −0.01, p < 0.001; PPMI‐cohort: β = −0.05, p = 0.05) and the putamen (primary‐cohort: β = −0.05, p = 0.02; PPMI‐cohort: β = −0.06, p = 0.02). Intriguingly, a lower lymphocyte count was significantly associated with lower DAT levels in both the caudate (primary‐cohort: β = +0.09, p < 0.05; PPMI‐cohort: β = +0.11, p = 0.02) and the putamen (primary‐cohort: β = +0.09, p < 0.05, PPMI‐cohort: β = +0.14, p = 0.01), but an association with the neutrophil count was not consistently observed (caudate; primary‐cohort: β = −0.05, p = 0.02; PPMI‐cohort: β = 0, p = 0.94; putamen; primary‐cohort: β = −0.04, p = 0.08; PPMI‐cohort: β = −0.01, p = 0.73).Conclusions: Our findings across two independent cohorts suggest a relationship between systemic inflammation and dopaminergic degeneration in patients with PD. This relationship was mainly driven by the lymphocyte count. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

31 January 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
LMLaura Muñoz-Delgado
Laura Muñoz-Delgado
DMDaniel Macías-García
Daniel Macías-García
MPMaría Teresa Periñán
María Teresa Periñán
SJSilvia Jesús
Silvia Jesús
AAAstrid D. Adarmes-Gómez
Astrid D. Adarmes-Gómez
PMPablo Mir
Pablo Mir
Peripheral inflammatory immune responses are thought to play a major role in the pathogenesis of Parkinson’s disease (PD). The neutrophil-to-lymphocyte ratio (NLR), a biomarker of systemic inflammation, has been reported to be higher in patients with PD than in healthy controls (HCs). The present study was aimed at determining if the peripheral inflammatory immune response could be influenced by the genetic background of patients with PD. We included a discovery cohort with 222 patients with PD (132 sporadic PD, 44LRRK2-associated PD (with p.G2019S and p.R1441G variants), and 46GBA-associated PD), as well as 299 HCs. Demographic and clinical data were recorded. Leukocytes and their subpopulations, and the NLR were measured in peripheral blood. Multivariate lineal regression and post-hoc tests were applied to determine the differences among the groups. Subsequently, a replication study using the Parkinson’s Progression Markers Initiative cohort was performed which included 401 patients with PD (281 sPD patients, 66LRRK2-PD patients, 54GBA-PD patients) and a group of 174 HCs. Patients with sporadic PD andGBA-associated PD showed a significantly lower lymphocyte count, a non-significantly higher neutrophil count and a significantly higher NLR than HCs. The peripheral inflammatory immune response of patients withLRRK2-associated PD did not differ from HCs. Our study supports the involvement of a peripheral inflammatory immune response in the pathophysiology of sPD andGBA-associated PD. However, this inflammatory response was not found inLRRK2-associated PD, probably reflecting different pathogenic inflammatory mechanisms.

1 April 2021 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
DGDavid García-Azorín
David García-Azorín
MAMaria Jose Abenza-Abildua
Maria Jose Abenza-Abildua
MEMaria Elena Erro
Maria Elena Erro
SFSantiago Fernández Fernández
Santiago Fernández Fernández
JGJuan Carlos García-Moncó
Juan Carlos García-Moncó
VCVictoriano Romero Cantero
Victoriano Romero Cantero

29 September 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
SPSara Picó
Sara Picó
APAlberto Parras
Alberto Parras
MSMaría Santos-Galindo
María Santos-Galindo
JPJulia Pose-Utrilla
Julia Pose-Utrilla
MCMargarita Castro
Margarita Castro
JLJosé J. Lucas
José J. Lucas
Altered CPEBs and mRNA polyadenylation lead to thiamine deficiency in the brains of patients and mice with Huntington’s disease.

16 July 2021 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
DMDaniel Macías-García
Daniel Macías-García
MPMaría Teresa Periñán
María Teresa Periñán
LMLaura Muñoz-Delgado
Laura Muñoz-Delgado
MJMaría Valle Jimenez-Jaraba
María Valle Jimenez-Jaraba
MLMiguel Ángel Labrador-Espinosa
Miguel Ángel Labrador-Espinosa
PMPablo Mir
Pablo Mir
Brain cholesterol metabolism has been described as altered in Parkinson’s disease (PD) patients. Serum lipid levels have been widely studied in PD with controversial results among different populations and age groups. The present study is aimed at determining if the serum lipid profile could be influenced by the genetic background of PD patients. We included 403 PD patients (342 sporadic PD patients, 30 GBA-associated PD patients, and 31 LRRK2-associated PD patients) and 654 healthy controls (HCs). Total cholesterol, HDL, LDL, and triglycerides were measured in peripheral blood. Analysis of covariance adjusting for sex and age (ANCOVA) and post hoc tests were applied to determine the differences within lipid profiles among the groups. Multivariate ANCOVA revealed significant differences among the groups within cholesterol and LDL levels. GBA-associated PD patients had significantly lower levels of total cholesterol and LDL compared to LRRK2-associated PD patients and HCs. The different serum cholesterol levels in GBA-associated PD might be related to diverse pathogenic mechanisms. Our results support the hypothesis of lipid metabolism disruption as one of the main PD pathogenic mechanisms in patients with GBA-associated PD. Further studies would be necessary to explore their clinical implications.

1 February 2021 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
SJSilvia Jesús
Silvia Jesús
IHIsabel Hinarejos
Isabel Hinarejos
FCFátima Carrillo
Fátima Carrillo
LMLola Martínez
Lola Martínez
DMDaniel Macías-García
Daniel Macías-García
Carmen EspinósCarmen Espinós
Carmen Espinós